← Leaderboards
Danish Saleheen
University Of Cambridge
$12,807,606
Attributed
$28,951,666
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.8M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,951,666 · 11
By mechanism
R01$18,902,759 · 7
RC2$7,967,526 · 1
RC1$999,986 · 1
P01$866,543 · 1
R21$214,852 · 1
Top collaborators
- Daniel James Rader21 shared
- John Navid Danesh11 shared
- Ira A Tabas4 shared
- Muredach P Reilly3 shared
- Philippe M. Frossard2 shared
- Ayeesha Kamran Kamal2 shared
- Dara Torgerson2 shared
- Jeffrey D Wall2 shared
Most similar at University Of Cambridge
Same institution · by research overlap
- John Navid Danesh$4,149,283
- Philippe M. Frossard$53,713
- Ayeesha Kamran Kamal$609,038
Others in their field
Top investigators on “Participant”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$407,724,307
- Lawrence Corey · Fred Hutchinson Cancer Center$333,313,234
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Albert Lazzarini · California Institute Of Technology$300,431,866
Research focus
ParticipantGeneticGenotypePakistanPathway InteractionsGenesPhenotypeCohortBiologicalGenome Wide Association StudyPlasmaLipidsMetabolicVariantResourcesLoss Of FunctionBiological MarkersEtiologyConsanguinityGenetic DeterminismTherapeutic TargetCellsKnock-OutSouth Asian
Grant awards (37)
Discovery of novel therapeutic targets for NASH through deep phenotyping of human knockouts and mechanistic studies$661,802
R01 · FY2025 · DK
Identification of smooth muscle cell genes causal in atherosclerotic plaque stability and cardiovascular disease risk$642,125
R01 · FY2025 · HL
Human Genetics and Phenotyping Core$285,375
P01 · FY2025 · HL · contact PI
Identification of smooth muscle cell genes causal in atherosclerotic plaque stability and cardiovascular disease risk$647,099
R01 · FY2024 · HL
Discovery of novel therapeutic targets for NASH through deep phenotyping of human knockouts and mechanistic studies$635,329
R01 · FY2024 · DK · contact PI
Human Genetics and Phenotyping Core$279,668
P01 · FY2024 · HL · contact PI
Identification of smooth muscle cell genes causal in atherosclerotic plaque stability and cardiovascular disease risk$692,449
R01 · FY2023 · HL
Discovery of novel therapeutic targets for NASH through deep phenotyping of human knockouts and mechanistic studies$661,802
R01 · FY2023 · DK · contact PI
Human Genetics and Phenotyping Core$301,500
P01 · FY2023 · HL · contact PI
Discovery of novel therapeutic targets for NASH through deep phenotyping of human knockouts and mechanistic studies$677,927
R01 · FY2022 · DK · contact PI
Deep phenotyping of ANGPTL3, ANGPTL4 and ANGPTL8 human knockouts and population based studies$619,439
R01 · FY2022 · HL · contact PI
Leveraging consanguinity and homozygosity to identify novel recessive variants$600,000
R01 · FY2022 · HG
Deep Phenotyping of ANGPTL3, ANGPTL4 and ANGPTL8 Human Knockouts and Population Based Studies$700,193
R01 · FY2021 · HL
Leveraging consanguinity and homozygosity to identify novel recessive variants$600,000
R01 · FY2021 · HG
Deep Phenotyping of ANGPTL3, ANGPTL4 and ANGPTL8 Human Knockouts and Population Based Studies$722,788
R01 · FY2020 · HL
Deep Phenotyping of Human Knockouts and Population Studies of the APOC3 Pathway$678,976
R01 · FY2020 · HL
Leveraging consanguinity and homozygosity to identify novel recessive variants$600,000
R01 · FY2020 · HG
Deep Phenotyping of ANGPTL3, ANGPTL4 and ANGPTL8 Human Knockouts and Population Based Studies$760,417
R01 · FY2019 · HL · contact PI
Deep Phenotyping of Human Knockouts and Population Studies of the APOC3 Pathway$692,812
R01 · FY2019 · HL
Leveraging consanguinity and homozygosity to identify novel recessive variants$620,000
R01 · FY2019 · HG
Deep Phenotyping of Human Knockouts and Population Studies of the APOC3 Pathway$699,514
R01 · FY2018 · HL · contact PI
Molecular mechanisms linking the CXCL12 pathway to atherosclerosis$687,311
R01 · FY2018 · HL
Deep Phenotyping of Human Knockouts and Population Studies of the APOC3 Pathway$753,746
R01 · FY2017 · HL · contact PI
Molecular mechanisms linking the CXCL12 pathway to atherosclerosis$704,966
R01 · FY2017 · HL · contact PI
Molecular mechanisms linking the CXCL12 pathway to atherosclerosis$733,396
R01 · FY2016 · HL · contact PI
Discovery and Validation of Novel Loci Associated with HDL Function$665,837
R01 · FY2016 · HL
Molecular mechanisms linking the CXCL12 pathway to atherosclerosis$791,469
R01 · FY2015 · HL · contact PI
Discovery and Validation of Novel Loci Associated with HDL Function$662,851
R01 · FY2015 · HL
Discovery and Validation of Novel Loci Associated with HDL Function$669,898
R01 · FY2014 · HL
Discovery and Validation of Novel Loci Associated with HDL Function$645,352
R01 · FY2013 · HL
Discovery and Validation of Novel Loci Associated with HDL Function$675,261
R01 · FY2012 · HL
Comprehensive biomarker study to capitalize on existing GWAS in 10K South Asians$4,199,069
RC2 · FY2010 · HL
Markers of the metabolic syndrome linking type 2 diabetes and MI in South Asia$499,993
RC1 · FY2010 · TW
Establishment of a bioresource for discovery and evaluation of genetic and other$106,920
R21 · FY2010 · NS
Comprehensive biomarker study to capitalize on existing GWAS in 10K South Asians$3,768,457
RC2 · FY2009 · HL
Markers of the metabolic syndrome linking type 2 diabetes and MI in South Asia$499,993
RC1 · FY2009 · TW
Establishment of a bioresource for discovery and evaluation of genetic and other$107,932
R21 · FY2009 · NS